May 16, 2019 Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (MMJFF – OTCQB) (39N – Frankfurt) (“Matica” or the “Company”) is pleased to announce the completion of the first cannabis harvest at the Dorval facility of RoyalMax Biotechnology Canada Inc. (“RoyalMax”). This is an important milestone for RoyalMax and Matica as the companies move towards retail and medical sales licensing.
“Our team, working in a state of the art facility, is producing the type of high quality product the market is demanding. This first harvest is important not just for our company but, for Quebec cannabis as a whole. With so few licence holders in the Province, more production of high quality cannabis from Quebec is an absolute must” states Boris Ziger, CEO of Matica, and adds that “I wish to thank our highly committed team and can’t express how proud I am of them.”
With the success of the first harvest, RoyalMax intends to follow up with a successful second harvest in the coming weeks. The third and fourth crops have already been placed in grow rooms populated with clones from our mother room. The facility will soon be running at full capacity with all grow rooms active. At full capacity RoyalMax plans a rotating schedule with harvests every two to three weeks.
Matica is a multi-faceted, innovative company in the Quebec cannabis space. RoyalMax Biotechnology Canada Inc. has been granted a standard cultivation licence by Health Canada for the production facility in Dorval, Quebec. Matica intends to build 1,000,000 square feet of greenhouses, in 200,000 square foot increments, on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for Matica and RoyalMax.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger, CEO & Chairman
The Company’s public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, at:
Suite 1102 – 44 Victoria Street
Toronto, ON, M5C 1Y2
Tel: (416) 304-9935
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.